 |
The NCI Director’s Consumer Liaison Group is a Federal Advisory Committee comprised of advocate leaders, chosen for their expert understanding of the perspectives and dynamics of the cancer research community. The DCLG indentifies and responds to issues and challenges facing the Institute at the request of the Director. The DCLG provides relevant, non-scientific skills and perspectives in order to improve research outcomes by identifying new approaches, promoting innovation, recognizing unforeseen risks or barriers, and identifying unintended consequences that could result from NCI decisions. Attend a DCLG meeting to see how the DCLG is involved in these areas! |
|
|
|
|
"I had an important message for summit attendees: They are our voice when it matters most. Advocates are the strong voice of cancer patients here at NCI and in all government forums - and the need for that voice is as great now as it has ever been."
NCI Director Dr. John Niederhuber |
|
|
